A citation-based method for searching scientific literature

Nicola Relitti, Akella P Saraswati, Stefano Federico, Tuhina Khan, Margherita Brindisi, Daniela Zisterer, Simone Brogi, Sandra Gemma, Stefania Butini, Giuseppe Campiani. Curr Top Med Chem 2020
Times Cited: 11







List of co-cited articles
46 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
54

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
266
27

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
848
27

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
27

A survey of telomerase activity in human cancer.
J W Shay, S Bacchetti. Eur J Cancer 1997
27

Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
A Zhang, C Zheng, C Lindvall, M Hou, J Ekedahl, R Lewensohn, Z Yan, X Yang, M Henriksson, E Blennow,[...]. Cancer Res 2000
115
27

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
201
27

Regulation of human telomerase in homeostasis and disease.
Caitlin M Roake, Steven E Artandi. Nat Rev Mol Cell Biol 2020
43
27


Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
Zachary Schrank, Nabiha Khan, Chike Osude, Sanjana Singh, Rachel J Miller, Collin Merrick, Alexander Mabel, Adijan Kuckovic, Neelu Puri. Molecules 2018
20
18

Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
Jian Hu, Soyoon Sarah Hwang, Marc Liesa, Boyi Gan, Ergun Sahin, Mariela Jaskelioff, Zhihu Ding, Haoqiang Ying, Adam T Boutin, Hailei Zhang,[...]. Cell 2012
180
18

Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.
Gabriela M Baerlocher, Elisabeth Oppliger Leibundgut, Oliver G Ottmann, Gary Spitzer, Olatoyosi Odenike, Michael A McDevitt, Alexander Röth, Michael Daskalakis, Bart Burington, Monic Stuart,[...]. N Engl J Med 2015
117
18

A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.
Ralph Salloum, Trent R Hummel, Shiva Senthil Kumar, Kathleen Dorris, Shaoyu Li, Tong Lin, Vinay M Daryani, Clinton F Stewart, Lili Miles, Tina Young Poussaint,[...]. J Neurooncol 2016
37
18

DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Ying Cao, Lily I Huschtscha, Andy C Chang, Amy Y M Au, Hilda A Pickett, Roger R Reddel. Nat Biotechnol 2009
264
18

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
209
18

DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
T R Devereux, I Horikawa, C H Anna, L A Annab, C A Afshari, J C Barrett. Cancer Res 1999
179
18

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
18

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar,[...]. Nat Genet 2015
184
18

Telomere Dysfunction, Chromosomal Instability and Cancer.
Jitendra Meena, K Lenhard Rudolph, Cagatay Günes. Recent Results Cancer Res 2015
23
18

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
18

Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Isabelle Guilleret, Pu Yan, Fabienne Grange, Richard Braunschweig, Fred T Bosman, Jean Benhattar. Int J Cancer 2002
173
18

TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas.
Matthias Simon, Ismail Hosen, Konstantinos Gousias, Sivaramakrishna Rachakonda, Barbara Heidenreich, Marco Gessi, Johannes Schramm, Kari Hemminki, Andreas Waha, Rajiv Kumar. Neuro Oncol 2015
103
18

Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
Yoshitaka Takuma, Kazuhiro Nouso, Yoshiyuki Kobayashi, Shinichiro Nakamura, Hironori Tanaka, Eiji Matsumoto, Tatsuya Fujikawa, Mayumi Suzuki, Tadashi Hanafusa, Yasushi Shiratori. J Gastroenterol Hepatol 2004
23
18

Telomerase as a Cancer Target. Development of New Molecules.
D L Mengual Gomez, R G Armando, C S Cerrudo, P D Ghiringhelli, D E Gomez. Curr Top Med Chem 2016
40
18

A phase II trial evaluating the clinical and immunologic response of HLA-A2(+) non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide.
Athanasios Kotsakis, Elisavet Papadimitraki, Eleni Kyriaki Vetsika, Despoina Aggouraki, Eleftheria Kleio Dermitzaki, Dora Hatzidaki, Nikolaos Kentepozidis, Dimitris Mavroudis, Vassilis Georgoulias. Lung Cancer 2014
35
18

Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.
Paal Fr Brunsvig, Jon Amund Kyte, Christian Kersten, Stein Sundstrøm, Mona Møller, Marta Nyakas, Gaute L Hansen, Gustav Gaudernack, Steinar Aamdal. Clin Cancer Res 2011
110
18

The Role of Alternative Lengthening of Telomeres Mechanism in Cancer: Translational and Therapeutic Implications.
Marta Recagni, Joanna Bidzinska, Nadia Zaffaroni, Marco Folini. Cancers (Basel) 2020
11
18

Optimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccines.
Jeanne Menez-Jamet, Catherine Gallou, Aude Rougeot, Kostas Kosmatopoulos. Ann Transl Med 2016
17
18

Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
Irini Bolonaki, Athanassios Kotsakis, Elsa Papadimitraki, Despoina Aggouraki, George Konsolakis, Aphrodite Vagia, Charalambos Christophylakis, Irini Nikoloudi, Elefterios Magganas, Athanassios Galanis,[...]. J Clin Oncol 2007
81
18

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.
Alessia Parodi, Florinda Battaglia, Francesca Kalli, Francesca Ferrera, Giuseppina Conteduca, Samuele Tardito, Silvia Stringara, Federico Ivaldi, Simone Negrini, Giacomo Borgonovo,[...]. Cancer Immunol Immunother 2013
39
18

Creation of human tumour cells with defined genetic elements.
W C Hahn, C M Counter, A S Lundberg, R L Beijersbergen, M W Brooks, R A Weinberg. Nature 1999
18

Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Cesare Gridelli, Tudor Ciuleanu, Manuel Domine, Aleksandra Szczesna, Isabel Bover, Manuel Cobo, Nikolaos Kentepozidis, Konstantinos Zarogoulidis, Charalabos Kalofonos, Andrzej Kazarnowisz,[...]. Br J Cancer 2020
5
40

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans.
B Minev, J Hipp, H Firat, J D Schmidt, P Langlade-Demoyen, M Zanetti. Proc Natl Acad Sci U S A 2000
211
18

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
Paal F Brunsvig, Steinar Aamdal, Marianne K Gjertsen, Gunnar Kvalheim, Carrie J Markowski-Grimsrud, Ingunn Sve, Marianne Dyrhaug, Sissel Trachsel, Mona Møller, Jon A Eriksen,[...]. Cancer Immunol Immunother 2006
161
18

Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001.
Eleni-Kyriaki Vetsika, Georgios Konsolakis, Despoina Aggouraki, Athanasios Kotsakis, Elisavet Papadimitraki, Soultana Christou, Jeanne Menez-Jamet, Kostas Kosmatopoulos, Vassilis Georgoulias, Dimitris Mavroudis. Cancer Immunol Immunother 2012
28
18

A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer.
Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Laura Tomasello, Simone Negrini, Francesca Kalli, Florinda Battaglia, Francesca Ferrera, Stefania Sciallero, Giuseppe Murdaca,[...]. Cancer Immunol Immunother 2013
38
18

Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one.
Daniela Fenoglio, Alessia Parodi, Rosa Lavieri, Francesca Kalli, Francesca Ferrera, Augusto Tagliamacco, Andrea Guastalla, Maria Giuseppina Lamperti, Mauro Giacomini, Gilberto Filaci. Hum Vaccin Immunother 2015
22
18


Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer.
Gilberto Filaci, Marco Fravega, Maurizio Setti, Paolo Traverso, Enrico Millo, Daniela Fenoglio, Simone Negrini, Francesca Ferrera, Andrea Romagnoli, Monica Basso,[...]. Blood 2006
44
18


Inhibition of telomerase limits the growth of human cancer cells.
W C Hahn, S A Stewart, M W Brooks, S G York, E Eaton, A Kurachi, R L Beijersbergen, J H Knoll, M Meyerson, R A Weinberg. Nat Med 1999
847
18

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
512
18

Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors.
A Prasanth Saraswati, Nicola Relitti, Margherita Brindisi, Sandra Gemma, Daniela Zisterer, Stefania Butini, Giuseppe Campiani. Drug Discov Today 2019
15
18

Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine.
Ilgen Mender, Sergei Gryaznov, Z Gunnur Dikmen, Woodring E Wright, Jerry W Shay. Cancer Discov 2015
58
18

Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.
Emanuelle Pascolo, Christian Wenz, Joachim Lingner, Norbert Hauel, Henning Priepke, Iris Kauffmann, Pilar Garin-Chesa, Wolfgang J Rettig, Klaus Damm, Andreas Schnapp. J Biol Chem 2002
187
18

MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.
Javier A Baena-Del Valle, Qizhi Zheng, David M Esopi, Michael Rubenstein, Gretchen K Hubbard, Maria C Moncaliano, Andrew Hruszkewycz, Ajay Vaghasia, Srinivasan Yegnasubramanian, Sarah J Wheelan,[...]. J Pathol 2018
26
18

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
171
9

Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis.
Rita T Lawlor, Nicola Veronese, Antonio Pea, Alessia Nottegar, Lee Smith, Camilla Pilati, Jacopo Demurtas, Matteo Fassan, Liang Cheng, Claudio Luchini. BMC Cancer 2019
17
9


In perspective: An update on telomere targeting in cancer.
Eric T Sugarman, Gao Zhang, Jerry W Shay. Mol Carcinog 2019
18
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.